Advances in Cancer Immunology and Immunotherapy

Advances in Cancer Immunology and Immunotherapy

Roman Anton

Contact

α The University of Truth and Common Sense, International

Advances in Cancer Immunology and Immunotherapy

Article Fingerprint

ReserarchID

APC16

Advances in Cancer Immunology and Immunotherapy Banner

AI TAKEAWAY

Connecting with the Eternal Ground

References

63 Cites in Article

Reference Format

Jacques Miller,Michel Sadelain (2015). The Journey from Discoveries in Fundamental Immunology to Cancer Immunotherapy.
Padmanee Sharma,Klaus Wagner,Jedd Wolchok,James Allison (2011). Novel cancer immunotherapy agents with survival benefit: recent successes and next steps.
Megan Mcnamara,Smita Nair,Eda Holl (2015). RNA-Based Vaccines in Cancer Immunotherapy.
A Patrick,F Hodi,H Kaufman,J Wigginton,J Wolchok (2017). Combination immunotherapy: a road map.
Nature (2012). Nature Reviews -Focus on Tumor Immunology and Immunotherapy; Table of Contents (publications herein).
A Sukari,M Nagasaka,A Al-Hadidi,L Lum (2016). Cancer Immunology and Immunotherapy.
Y Yang (2015). Cancer immunotherapy: harnessing the immune system to battle cancer.
Cell (2015). Cancer, Immunity, and Immunotherapy -Reviews from Cancer Cell and Trends in Immunology.
C Voena,R Chiarle (2016). Advances in cancer immunology and cancer immunotherapy.
Kimberly Miller,Rebecca Siegel,Chun Lin,Angela Mariotto,Joan Kramer,Julia Rowland,Kevin Stein,Rick Alteri,Ahmedin Jemal (2016). Cancer treatment and survivorship statistics, 2016.
(2018). FDA drug approvals.
Ksp (2017). Global Cancer Immunotherapy Market Analysis & Forecast to.
P Taylor (2017). The top 15 best-selling cancer drugs in 2022.
J Scannell,J Bosley (2016). When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisis.
James March (1991). Exploration and Exploitation in Organizational Learning.
Abraham Carmeli,Meyrav Halevi (2009). How top management team behavioral integration and behavioral complexity enable organizational ambidexterity: The moderating role of contextual ambidexterity.
Ramana Nanda (2016). Financing high-potential entrepreneurship.
R Choi (2015). Increasing Transparency of Clinical Trial Data in the United States and the European Union.
G Forni (2015). Vaccines for tumor prevention: a pipe dream?.
G Stevenson (2014). Three major uncertainties in the antibody therapy of cancer.
Jacques Descotes (2009). Immunotoxicity of monoclonal antibodies.
Frank Brennan,Laura Morton,Sebastian Spindeldreher,Andrea Kiessling,Roy Allenspach,Adam Hey,Patrick Müller,Werner Frings,Jennifer Sims (2010). Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies.
D Lee (2014). Lee DW, Gardner R, Porter DL, et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124(2):188-195..
A Mirsoian (2014). Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice.
Chunpeng Yang,Xinyu Gao,Rui Gong (2017). Engineering of Fc Fragments with Optimized Physicochemical Properties Implying Improvement of Clinical Potentials for Fc-Based Therapeutics.
Richard Larson,Navid Ghaffarzadegan,Yi Xue (2015). Too Many PhD Graduates or Too Few Academic Job Openings: The Basic Reproductive Number R0 in Academia.
Bruce Alberts,Marc Kirschner,Shirley Tilghman,Harold Varmus (2014). Rescuing US biomedical research from its systemic flaws.
Troy Shinbrot (1999). Exploitation of junior scientists must end.
Saskia Meyer,Jeanette Leusen,Peter Boross (2014). Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer.
Gregory Moore,Hsing Chen,Sher Karki,Greg Lazar (2010). Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions.
E Walter (1995). Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.
Cri (2018). Timeline of Cancer Immunotherapy.
Nina Pilat,Mohamed Sayegh,Thomas Wekerle (2011). Costimulatory pathways in transplantation.
Steven Rosenberg,Nicholas Restifo,James Yang,Richard Morgan,Mark Dudley (2008). Adoptive cell transfer: a clinical path to effective cancer immunotherapy.
William Ho,Joseph Blattman,Michelle Dossett,Cassian Yee,Philip Greenberg (2003). Adoptive immunotherapy: Engineering T cell responses as biologic weapons for tumor mass destruction.
Michael Kalos,Carl June (2014). Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology.
M Wang,B Yin,H Wang,R Wang (2014). Current advances in T-cell-based cancer immunotherapy.
S Rosenberg,N Restifo (2015). Adoptive cell transfer as personalized immunotherapy for human cancer.
Y Kong,J Zhang,D Claxton,W Ehmann,W Rybka,L Zhu,H Zeng,T Schell,H Zheng (2015). PD-1hiTIM-3+ T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation.
Olle Ringdén,Helen Karlsson,Richard Olsson,Brigitta Omazic,Michael Uhlin (2009). The allogeneic graft‐versus‐cancer effect.
Giao Phan,Steven Rosenberg (2013). Adoptive Cell Transfer for Patients with Metastatic Melanoma: The Potential and Promise of Cancer Immunotherapy.
S Lindegaard (2010). The open innovation revolution -Esssentials, roadblocks, and leadership skills.
H Chesbrough (2003). Open Innovation: the new imperative for creating and profiting from technology.
Y Jiang,Y Li,B Zhu (2015). T-cell exhaustion in the tumor microenvironment.
H Symons (2008). The allogeneic effect revisited: exogenous help for endogenous, tumor-specific T cells.
Julie Curtsinger,Matthew Mescher (2016). Inflammatory cytokines as a third signal for T cell activation.
A Corthay (2006). A Three‐cell Model for Activation of Naïve T Helper Cells.
Vita Golubovskaya,Lijun Wu (2016). Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy.
G Chunqing,M Manjili,R John,S Devanand,B Paul,X Wang (2014). Therapeutic Cancer Vaccines.
Giorgio Parmiani,Vincenzo Russo,Cristina Maccalli,Danilo Parolini,Nathalie Rizzo,Michele Maio (2015). Peptide-based vaccines for cancer therapy.
F González,A Gleisner,F Falcón-Beas,F Osorio,N López,F Salazar-Onfray (2014). Tumor cell lysates as immunogenic sources for cancer vaccine design.
Arianna Palladini,Susan Thrane,Christoph Janitzek,Jessica Pihl,Stine Clemmensen,Willem De Jongh,Thomas Clausen,Giordano Nicoletti,Lorena Landuzzi,Manuel Penichet,Tania Balboni,Marianna Ianzano,Veronica Giusti,Thor Theander,Morten Nielsen,Ali Salanti,Pier-Luigi Lollini,Patrizia Nanni,Adam Sander (2018). Virus-like particle display of HER2 induces potent anti-cancer responses.
C Dale,Scott Thomson,Robert De Rose,Charani Ranasinghe,C Medveczky,Joko Pamungkas,David Boyle,Ian Ramshaw,Stephen Kent (2006). Prime-Boost Strategies in DNA Vaccines.
Bo Xiang,Trevor Baybutt,Lisa Berman-Booty,Michael Magee,Scott Waldman,Vitali Alexeev,Adam Snook (2017). Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+ T Cells.
Paweł Kawalec,Anna Paszulewicz,Przemysław Holko,Andrzej Pilc (2012). Systematic review/Meta-analysis Sipuleucel-T immunotherapy for castration-resistant prostate cancer. A systematic review and meta-analysis.
Christopher Pannucci,Edwin Wilkins (2011). Identifying and Avoiding Bias in Research.
Michael Mahoney (1977). Publication prejudices: An experimental study of confirmatory bias in the peer review system.
Roman Anton (2017). Falseness in the miRNA-field as an indicator of strategic bias in the research system via peer-review and publishing eligibility.
Hannah Rothstein,Alexander Sutton,Michael Borenstein (2005). Publication Bias in Meta‐Analysis.
John Ioannidis (2005). Why Most Published Research Findings Are False.
Henry Bourne (2013). A fair deal for PhD students and postdocs.
Vishwanath Sathyanarayanan,Sattva Neelapu (2015). Cancer immunotherapy: Strategies for personalization and combinatorial approaches.
Irene Moya-Horno,Santiago Viteri,Niki Karachaliou,Rafael Rosell (2018). Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC).

Download References

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Roman Anton. 2018. \u201cAdvances in Cancer Immunology and Immunotherapy\u201d. Global Journal of Medical Research - F: Diseases GJMR-F Volume 18 (GJMR Volume 18 Issue F2): .

More Citation Formats

Select Citation Style:

Download Citation

Download Article

GJMR Volume 18 Issue F2
Pg. 33- 56

Explore Journals Explore Volume Read This Issue

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords

Not Found

Classification

GJMR-F Classification: NLMC Code: QZ 20.5

Submission ReceivedDecember 8, 2017
Peer Review Double Blind
Handling Editor
Accepted January 4, 2018
Published January 15, 2018

Version of record

v1.2

Issue date

August 6, 2018

Language

Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

View in VR

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

View in 3D

Article Matrices

Total Score: 111

Country: Germany

Subject: Global Journal of Medical Research - F: Diseases

Authors: Roman Anton (PhD/Dr. count: 0)

View Count (all-time): 132

Total Views (Real + Logic): 3050

Total Downloads (simulated): 1442

Publish Date: 2018 08, Mon

Monthly Totals (Real + Logic):

Month 1: 53 views
Month 2: 39 views
Month 3: 46 views
Month 4: 65 views
Month 5: 61 views
Month 6: 51 views
Month 7: 33 views
Month 8: 38 views
Month 9: 46 views
Month 10: 56 views
Month 11: 27 views
Month 12: 17 views
Month 13: 39 views
Month 14: 34 views
Month 15: 29 views
Month 16: 27 views
Month 17: 25 views
Month 18: 14 views
Month 19: 19 views
Month 20: 25 views
Month 21: 21 views
Month 22: 32 views
Month 23: 33 views
Month 24: 36 views
Month 25: 18 views
Month 26: 39 views
Month 27: 33 views
Month 28: 22 views
Month 29: 29 views
Month 30: 30 views
Month 31: 33 views
Month 32: 32 views
Month 33: 28 views
Month 34: 35 views
Month 35: 25 views
Month 36: 27 views
Month 37: 37 views
Month 38: 21 views
Month 39: 32 views
Month 40: 25 views
Month 41: 28 views
Month 42: 30 views
Month 43: 26 views
Month 44: 32 views
Month 45: 32 views
Month 46: 25 views
Month 47: 28 views
Month 48: 41 views
Month 49: 31 views
Month 50: 32 views
Month 51: 34 views
Month 52: 29 views
Month 53: 24 views
Month 54: 28 views
Month 55: 32 views
Month 56: 42 views
Month 57: 28 views
Month 58: 16 views
Month 59: 31 views
Month 60: 33 views
Month 61: 33 views
Month 62: 34 views
Month 63: 12 views
Month 64: 40 views
Month 65: 23 views
Month 66: 20 views
Month 67: 20 views
Month 68: 28 views
Month 69: 40 views
Month 70: 27 views
Month 71: 44 views
Month 72: 38 views
Month 73: 29 views
Month 74: 39 views
Month 75: 33 views
Month 76: 43 views
Month 77: 43 views
Month 78: 22 views
Month 79: 29 views
Month 80: 23 views
Month 81: 31 views
Month 82: 22 views
Month 83: 22 views
Month 84: 28 views
Month 85: 37 views
Month 86: 13 views
Month 87: 29 views
Month 88: 34 views
Month 89: 28 views
Month 90: 22 views
Month 91: 47 views
Month 92: 45 views
Month 93: 31 views

Total Views: 3050

Total Downloads: 1442

2026 Trends

Published Article

Abstract not found

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]